Ondine Biomedical Inc

Research Ondine Biomedical Inc (OBI) on Bullrun: market cap GBX 7.66B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerOBI
• ExchangeLSE
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyGBX
• Market capGBX 7.66B
• Financial periodFY2024
• RevenueGBP 2.05M
• Revenue growth70.3%
• Net income-GBP 19.10M
• Free cash flow-GBP 15.50M
• Gross margin64.5%

Valuation Snapshot

latest market cap is GBX 7.66B.

About Ondine Biomedical Inc

Ondine Biomedical Inc., a life-sciences company, engages in the development of activated antimicrobial therapies for the prevention and treatment of infections in Canada and internationally. Its primary product is Steriwave, a non-invasive, nurse-administered treatment that eliminates harmful bacteria, viruses, and fungi from the nose.

Frequently asked questions

What is Ondine Biomedical Inc's market cap?

Ondine Biomedical Inc's market capitalization is GBX 7.66B.

What does Ondine Biomedical Inc do?

Ondine Biomedical Inc., a life-sciences company, engages in the development of activated antimicrobial therapies for the prevention and treatment of infections in Canada and internationally.